Atheroprotective immunity and cardiovascular disease: therapeutic opportunities and challenges

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2796|278|5|507-519

ISSN： 0954-6820

Source： JOURNAL OF INTERNAL MEDICINE, Vol.278, Iss.5, 2015-11, pp. : 507-519

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The metabolic syndrome and neuropathy: Therapeutic challenges and opportunities

By  

ANNALS OF NEUROLOGY, Vol. 74, Iss. 3, 2013-09 ,pp. : 397-403

John Wiley & Sons Inc

Access to resources Recommend Favorite

Anaphylaxis and cardiovascular disease: therapeutic dilemmas

By  

CLINICAL & EXPERIMENTAL ALLERGY, Vol. 45, Iss. 8, 2015-08 ,pp. : 1288-1295

John Wiley & Sons Inc

Access to resources Recommend Favorite

Therapeutic potential of midkine in cardiovascular disease

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 171, Iss. 4, 2014-02 ,pp. : 936-944

John Wiley & Sons Inc

Access to resources Recommend Favorite

Nanomedicine opportunities for cardiovascular disease with perfluorocarbon nanoparticles

By Lanza Gregory M   Winter Patrick M   Caruthers Shelton D   Hughes Michael S   Cyrus Tillmann   Marsh Jon N   Neubauer Anne M   Partlow Kathy C   Wickline Samuel A  

Nanomedicine, Vol. 1, Iss. 3, 2006-10 ,pp. : 321-329

Future Medicine

Access to resources Recommend Favorite

Sympathetic activation in cardiovascular disease: evidence, clinical impact and therapeutic implications

By  

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (ELECTRONIC), Vol. 45, Iss. 12, 2015-12 ,pp. : 1367-1375

John Wiley & Sons Inc

Access to resources Recommend Favorite